Prelude Therapeutics Incorporated has grown revenue 73% a year over three years and 73% a year over five. Revenue growth, 3-year annual rate: +73% (Biotechnology median +17%). Revenue growth, 5-year rate: +73%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

PRLDPrelude Therapeutics Incorporated

Healthcare

$3.88+169% 1Y

$3.88

$1.1952 weeks$6.62

Is it growing?

Good

Revenue growing +220% year on year. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data

Revenue trend+220% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PRLD growing?

Prelude Therapeutics Incorporated has grown revenue 73% a year over three years and 73% a year over five.

+73%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +73%
Revenue growth, 5-year rate · +73% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›